Technical Analysis for MBIO - Mustang Bio, Inc.

Grade Last Price % Change Price Change
grade D 7.47 1.22% 0.09
MBIO closed up 1.22 percent on Thursday, July 19, 2018, on 25 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical MBIO trend table...

Date Alert Name Type % Chg
Jul 19 Crossed Above 50 DMA Bullish 0.00%
Jul 18 NR7 Range Contraction 1.22%
Jul 17 50 DMA Resistance Bearish 3.32%
Jul 17 180 Bearish Setup Bearish Swing Setup 3.32%
Jul 16 50 DMA Resistance Bearish 0.27%
Jul 16 Hammer Candlestick Bullish 0.27%
Jul 16 Doji - Bullish? Reversal 0.27%
Jul 16 Weak + Overbought Other 0.27%
Jul 16 Overbought Stochastic Strength 0.27%
Jul 13 50 DMA Resistance Bearish -0.27%

Older signals for MBIO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patient’s own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments, including human epidermal growth factor receptor 2 CAR T technology, CS1-specific CAR T technology, and prostate stem cell antigen CAR T technology.
Is MBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.35
52 Week Low 6.17
Average Volume 115,454
200-Day Moving Average 9.8321
50-Day Moving Average 7.4226
20-Day Moving Average 7.192
10-Day Moving Average 7.42
Average True Range 0.4674
ADX 14.85
+DI 13.7673
-DI 13.2523
Chandelier Exit (Long, 3 ATRs ) 6.2978
Chandelier Exit (Short, 3 ATRs ) 7.5722
Upper Bollinger Band 7.7159
Lower Bollinger Band 6.6681
Percent B (%b) 0.77
BandWidth 14.568966
MACD Line -0.0041
MACD Signal Line -0.0612
MACD Histogram 0.0571
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.97
Resistance 3 (R3) 7.92 7.71 7.88
Resistance 2 (R2) 7.71 7.58 7.73 7.85
Resistance 1 (R1) 7.59 7.51 7.65 7.64 7.83
Pivot Point 7.38 7.38 7.41 7.40 7.38
Support 1 (S1) 7.26 7.25 7.32 7.31 7.11
Support 2 (S2) 7.05 7.18 7.07 7.09
Support 3 (S3) 6.93 7.05 7.06
Support 4 (S4) 6.98